Close mobile menu×
Close mobile menu

Anjali Saqi, MD, MBA

Board Certifications: 
Pathology-Anatomic/Pathology-Clinical, Cytopathology
Expertise in: 
Lung Cancer
Accepting New Patients
Profile Headshot

Appointments

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Pathology-Anatomic/Pathology-Clinical
  • Cytopathology

Clinical Expertise

  • Lung Cancer
  • Surgical Pathology
  • Pulmonary Pathology
  • Pancreatobiliary Disease
  • Cytopathology

Specialties

Education & Training

  • State University of New York - Downstate Health Sciences Center
  • MD, 1996 State University of New York Health Science Center at Brooklyn
  • Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: Hospital of the University of Pennsylvania

Honors & Awards

Castle Connolly Top Doctor

Academy of Clinical Excellence

About Anjali Saqi

Dr. Saqi is a Professor in the Department of Pathology & Cell Biology at Columbia University Medical Center. She is triple board certified, practices surgical pathology and cytopathology. Her interests include pulmonary pathology and pancreatico-biliary cytopathology with a focus in maximizing results, including molecular diagnoses, on small samples. She also earned her MBA from Columbia Business School. With her experiences and education, she is actively involved in teaching, conducting clinical research, and working hands-on in collaboration with others on innovative solutions to improve the quality of healthcare.

Email: aas177@cumc.columbia.edu

Academic Titles

  • Professor of Pathology & Cell Biology at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • Hindi
  • Punjabi

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Research

Grants

SERVICE AGREEMENT GO40241 (P&S Industry Clinical Trial)

Mar 29 2018 - Mar 29 2023

SUBCLINICAL INTERSTITIAL LUNG DISEASE IN MESA AND FAR-ILD (Federal Gov)

May 1 2017 - Apr 30 2021

Selected Publications

Saqi A. The State of Cell Blocks and Ancillary Testing: Past, Present, and Future. Arch Pathol Lab Med. 2016 Dec;140(12):1318-1322.

Kim J, Thomashow B, Saqi A. Pulmonary Cavitary Lesion and Haemoptysis: Rare Aetiology on Biopsy. BMJ Case Rep. 2016.

Coley SM, J. P. Crapanzano, A. Saqi.  "FNA, Core Biopsy, or Both for Diagnosis of Lung Carcinoma: Obtaining Sufficient Tissue for a Specific Diagnosis and Molecular Testing." Cancer Cytopathol. 2015 May;123(5):318-26.

Saqi A. A.P. Kuker, S. A. Ebner, J. Ausiello, V. Jobanputra, G. Bhagat, T. A. Giorgadze. Langerhans Cell Histiocytosis: Diagnosis on Thyroid Aspirate and Review of the Literature. Head Neck Pathol. 2015 Dec;9(4):496-502.

Salomao M, T. A. Gonda, E. Margolskee, V. Eguia, H. Remotti, J. M. Poneros, A. Sethi, A Saqi. "Strategies for Improving Diagnostic Accuracy of Biliary Strictures." Cancer Cytopathol. 2015 Apr;123(4):244-52.

Pareja F, J. P. Crapanzano, M. M. Mansukhani, W. A. Bulman, A. Saqi. "Cytomorphological features of ALK-positive lung adenocarcinomas: Psammoma bodies and signet ring cells." Cancer Cytopathol. 2015 Mar;123(3):162-70.

Heymann JJ, W. A. Bulman, R. A. Maxfield, C. A. Powell, B. Halmos, J. Sonett, N.T. Beaubier, J. P. Crapanzano, M. Mansukhani, A. Saqi. “Molecular Testing Guidelnes For Lung Adenocarcinoma: Utility Of Cell Blocks And Concordance Between Fine Needle Aspiration Cytology And Histology Samples.” Cytojournal. 2014 May 22;11:12.

Crapanzano JP, J. J. Heymann, S. Monaco, A. Nassar, A. Saqi. The State Of Cell Block Variation And Satisfaction In The Era Of Molecular Diagnostics And Personalized Medicine. Cytojournal. 2014 March 20;11:7.

Saqi, A., S. M. Coley and J. P. Crapanzano. Granulomatous Inflammation and Organizing Pneumonia: Role of Computed Tomography-Guided Lung Fine Needle Aspirations, Touch Preparations and Core Biopsies in the Evaluation of Common Non-Neoplastic Diagnoses. Cytojournal. 2014 Jan 31;11:2.

Salomao, M., H. Remotti, J. D. Allendorf, J. M. Poneros, A. Sethi, T. A. Gonda and A. Saqi. Fine-Needle Aspirations of Pancreatic Serous Cystadenomas: Improving Diagnostic Yield with Cell Blocks and Alpha-Inhibin Immunohistochemistry. Cancer Cytopathol 122, no. 1 (2014): 33-9.